Ann Lab Med.  2015 Sep;35(5):540-541. 10.3343/alm.2015.35.5.540.

The e1a3 BCR-ABL1 Fusion Transcript in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

• Langabeer

• KMID: 2369772
• DOI: http://doi.org/10.3343/alm.2015.35.5.540

Abstract

No abstract available.

MeSH Terms

Precursor Cell Lymphoblastic Leukemia-Lymphoma*

Reference

1. Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript. Ann Lab Med. 2015; 35:159–161. PMID: 25553301.

2. Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion. Acta Haematol. 2011; 126:214–215. PMID: 21934295.

3. Chen Y, Wang HW, Chen XH, Xu ZF, Qin YH, Ren FG, et al. Adult acute lymphoblastic leukemia with atypical BCR-ABL transcript e1a3: a case report and literature review. Zhonghua Xue Ye Xue Za Zhi. 2013; 34:965–966. PMID: 24294854.

4. McCarron SL, Haslam K, Kelly J, Duggan C, Langabeer SE. A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia. Int J Lab Hematol. 2012; 34:e1–e2. PMID: 21692997.

5. Park TS, Kim JS, Song J, Lee KA, Yoon S, Suh B, et al. Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis. Cancer Genet Cytogenet. 2009; 188:103–107. PMID: 19100514.

6. Ravandi F, Jorgensen JL, Thomas DA, O'Brien S, Garris R, Faderl S, et al. Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood. 2013; 122:1214–1221. PMID: 23836561.